STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIT
  4. [Form 4] Health In Tech, Inc. Insider Trading Activity

Health In Tech insider files Form 4 reporting 7,000 restricted Class A shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Health In Tech insider Jonathan Del Lockett reported a grant of 7,000 restricted shares of Class A common stock on 08/15/2025. The restricted shares were granted under the Health in Tech Equity Incentive Plan and carry vesting conditions tied to the successful launch and full operation of two specified company programs: 50% of the restricted shares vest monthly over 12 months after the first program is launched, and the remaining 50% vest monthly over 12 months after the second program is launched. Following the reported transaction, Mr. Lockett beneficially owns 93,539 shares (including 22,105 restricted shares and 71,434 unrestricted Class A shares); the filing notes he also holds 165,085 options to purchase Class A common stock that are excluded from the ownership total.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine executive equity grant with performance-contingent vesting; disclosure aligns with Section 16 reporting requirements.

The Form 4 documents a standard restricted stock award to a named officer under the company equity plan. Vesting is conditional on commercial launch milestones for two company programs, which ties executive incentives directly to product execution. The filing clearly discloses post-transaction beneficial ownership and outstanding option counts. This is a governance-appropriate disclosure and does not, by itself, signal material corporate change.

TL;DR: Grant size is modest relative to outstanding options; vesting structure ties pay to operational milestones.

The award of 7,000 restricted shares aligns executive compensation with milestone delivery by splitting vesting across two program launches. The filing also notes 165,085 options outstanding held by the reporting person, which could represent future potential dilution depending on exercise terms. The disclosed beneficial ownership of 93,539 shares (including 22,105 restricted) provides clear context for current equity stake.

Insider Lockett Jonathan Del
Role Chief Strategy Officer
Type Security Shares Price Value
Grant/Award Class A Common Stock 7,000 $0.00 --
Holdings After Transaction: Class A Common Stock — 93,539 shares (Direct)
Footnotes (1)
  1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace. Includes 71,434 shares of Class A Common Stock and 22,105 shares of restricted stock. Excludes 165,085 options to purchase shares of Class A Common Stock.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lockett Jonathan Del
(Last) (First) (Middle)
701 S. COLORADO AVE,SUITE 1
(Street)
STUART FL 34994
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Strategy Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/15/2025 A 7,000(1) A $0 93,539(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Fifty percent (50%) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of two specified programs being developed by the Company is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other specified program being developed by the Company is successfully launched and fully operational in the marketplace.
2. Includes 71,434 shares of Class A Common Stock and 22,105 shares of restricted stock. Excludes 165,085 options to purchase shares of Class A Common Stock.
/s/ (Jonathan) Del Lockett 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Jonathan Del Lockett report on Form 4 for HIT?

He reported a grant of 7,000 restricted shares of Class A common stock on 08/15/2025 under the Health in Tech Equity Incentive Plan.

How do the restricted shares vest for the HIT grant?

50% of the restricted shares vest in equal monthly installments over 12 months after the first specified program is launched and operational; the remaining 50% vest similarly after the second specified program is launched and operational.

How many shares does Mr. Lockett beneficially own after the transaction?

The filing reports 93,539 shares beneficially owned following the transaction, consisting of 71,434 Class A shares and 22,105 restricted shares.

Are there other equity instruments held by the reporting person?

Yes. The filing states the reporting person holds 165,085 options to purchase Class A common stock, which are excluded from the reported beneficial ownership figure.

When was the Form 4 signed and filed?

The signature on the Form 4 is dated 08/19/2025 and the reported transaction date is 08/15/2025.